Minnesota Administrative Rules

4770.1800 INVENTORY.

Subpart 1.

Controls and procedures.

A medical cannabis manufacturer must establish inventory controls and procedures for conducting inventory reviews and comprehensive inventories of plant material and medical cannabis to prevent and detect any diversion, theft, or loss in a timely manner.

Subp. 2.

Reliable and ongoing supply.

A medical cannabis manufacturer must provide a reliable and ongoing supply of medical cannabis as required by Minnesota Statutes, section 152.29, subdivision 2.

Subp. 3.

Real-time inventory.

A medical cannabis manufacturer must maintain a real-time record of its inventory of plant material and medical cannabis to include:

A.

the date and time of the inventory;

B.

a summary of inventory findings, including:

(1)

the weight of cannabis seeds by type, strain, and cultivar;

(2)

the total count of plants, whether in the flowering, vegetative, or clone phase of growth and organized by room in which the plants are grown;

(3)

the batch number, weight or unit count, and strain name associated with each batch at the production facility that has been prepared for testing or is ready for transport to a distribution facility;

(4)

the total number of plants that have been harvested but are not yet associated with a batch and every unique plant identifier;

(5)

the amount of acquired industrial hemp; and

(6)

the amount of medical cannabis, either by weight or units, sold since previous inventory and listed by product name and registry identifier;

C.

the names of the employees or employee conducting the inventory; and

D.

other information deemed necessary and requested by the commissioner.

Subp. 4.

Waste inventory.

The medical cannabis manufacturer must maintain a real-time record of its inventory of all medical cannabis waste, including damaged, defective, expired, contaminated, recalled, or returned medical cannabis for disposal, and plant material waste for disposal.

Subp. 5.

Reconciliation.

At the close of business each day, a medical cannabis manufacturer must reconcile by conducting a physical inventory of all:

A.

plant material at the manufacturing facility and in transit; and

B.

medical cannabis at the manufacturing facility, each distribution facility, and in transit.

Subp. 6.

Scales.

All scales used to weigh usable plant material for purposes of this chapter must be certified in accordance with the International Organization for Standardization (ISO), ISO/IEC Standard 17025, which is incorporated by reference.

Subp. 7.

Discrepancies.

If discrepancies are discovered outside of loss standard to the industry due to moisture loss and handling, the manufacturer must investigate the discrepancy and must submit a report of its investigation to the commissioner within seven days. If a discrepancy is due to suspected criminal activity, the manufacturer must notify the commissioner and appropriate law enforcement agencies in writing within 24 hours.

Statutory Authority:

MS s 14.389; 152.25; 152.26

History:

39 SR 1080; 46 SR 1011

Published Electronically:

June 15, 2022